North America Smart Pills Market Forecast to 2028

North America Smart Pills Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), and End User (Hospitals and Clinics, Research Institutes, and Home Healthcare)

Report Code : BMIRE00025431 | Region : North America | Industry : Pharmaceuticals | Published Date : 21/Jul/2022

The North America smart pills market is expected to reach US$ 5,300.85 million by 2028 from US$ 2,314.71 million in 2021. The market is estimated to grow at a CAGR of 12.6% from 2021 to 2028.

The geriatric population is highly vulnerable to gastrointestinal disorders. Various smart pills are now being analyzed for potential application in therapeutics and diagnosing several acute and chronic diseases. Patients with chronic diseases who follow a specified dose of medication at the target site are anticipated to form a large customer base for advanced drug delivery products. The increasing demand for minimally invasive surgical procedures has led to innovative techniques such as capsule endoscopy. Capsule endoscopy is expected to replace traditional endoscopy methods due to its advantages, including ease of administration and detailed observation of the gastrointestinal tract. The capsule endoscopy plays a vital role in the early diagnosis and proper treatment of these disorders, along with hybrid imaging technologies and new component innovations. For instance, as per the University of Texas Health Science Center, the deployment of various colorectal cancer screening procedures, such as capsule endoscopy, improves adherence to screening. The university conducted a study comprising randomly assigned patients aged 50 to 75 and inferred that capsule endoscopy gives better diagnostic results than CT colonography. Such findings are estimated to boost the segment growth over the forecast period. Patients with a maximal requirement for home healthcare services face challenges concerning access and use of smart pills. This has resulted in developers and producers increasing the accessibility and usability of these devices, thereby facilitating the interpretation of data more simply. Most industries offer compatible software for collecting data over a longer duration, conveying valuable information about patient health, and providing suggestions for enhancing their quality of life. Being connected to smartphones through Bluetooth and providing data in user-friendly & statistical format is boosting the demand for smart pills.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the smart pills market. The North America smart pills market is expected to grow at a good CAGR during the forecast period.

North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

North America Smart Pills Market Segmentation

The North America smart pills market is segmented based on application, disease indication, and end user. Based on application, the market is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment is sub segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscopy, and other capsule endoscopy. Based on disease indication, the market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the market is segmented into hospitals and clinics, research institutes, and home healthcare. By Country, the North America smart pills market is segmented into the US, Mexico, and Canada.

North America Smart Pills Market – Companies Mentioned

Capso Vision, Inc.; Medtronic; Check-Cap; PENTAX Medical; Olympus Corporation; and Otsuka Holdings Co., Ltd are among the leading companies in the North America smart pills market.

Capsule Endoscopy segment has the Largest Share of Application in the North America Smart Pills Market during 2019–2028

According to our latest study on “North America Smart Pills Market Forecast to 2028 – COVID-19 Impact and Analysis – by “Application, Disease Indication and End User ” the market is projected to reach US$ 5,300.85 million by 2028 from US$ 2,314.71 million in 2021; it is expected to grow at a CAGR of 12.6% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as rising demand for minimally invasive surgical and increase in the strategic collaboration & partnerships on smart pills. However, high cost of smart pill is hamper the market growth.

The smart pills market, based on application, has been segmented into capsule endoscopy, drug delivery and patient monitoring. The capsule endoscopy segment is likely to hold the largest share of the market in 2021. Moreover, the drug delivery segment is anticipated to register the highest CAGR in the market during the forecast period of 2021 to 2028. This is mainly because smart pill with environmental sensors, a feedback algorithm and a drug release mechanism can lead to smart drug delivery systems, supportive technologies resulting in accounting high CAGR during the forecast period.

Capso Vision, Inc., Medtronic, Check-Cap, PENTAX Medical, Olympus Corporation and Otsuka Holdings Co., Ltd are among the leading companies in the North America smart pills market .The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for North America smart pills market is segmented into application, disease indication and end user. Based on application, the market is segmented into capsule endoscopy, drug delivery, and patient monitoring and capsule endoscopy sub segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscope and other capsule endoscopy. Based on disease indication, the market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the North America smart pills market is segmented into hospitals and clinics, research institutes, and home healthcare. By Country, the North America smart pills market is segmented into US, Mexico and Canada.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Smart Pills Market – By Application

1.3.2 North America Smart Pills Market – By Disease Indication

1.3.3 North America Smart Pills Market – By End User

1.3.4 North America Smart Pills Market – By Country

2. North America Smart Pills Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Smart Pills Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.3 Expert Opinion

5. North America Smart Pills Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Demand for Minimally Invasive Surgical Procedures

5.1.2 Increase in Strategic Collaborations & Partnerships On Smart Pills

5.2 Market Restraints

5.2.1 High Cost of Smart Pill

5.3 Market Opportunities

5.3.1 Increasing Demand for Drug Delivery System

5.4 Future Trends

5.4.1 Remote Patient Monitoring Through Smart Pills

6. North America Smart Pills Market –Country Analysis

6.1 North America Smart Pills Market Revenue Forecast and Analysis

6.1.1 North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

7. North America Smart Pills Market Analysis – By Application

7.1 Overview

7.2 North America Smart Pills Market, By Application, 2021 & 2028 (%)

7.2.1 North America North America Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)

7.2.1.1 North America North America Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)

7.3 Capsule Endoscopy

7.3.1 Overview

7.3.2 Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

7.3.3 Small Bowel Video Capsule Endoscopy

7.3.3.1 Overview

7.3.3.2 Small Bowel Video Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

7.3.4 Colon Capsule Endoscopy

7.3.4.1 Overview

7.3.4.2 Colon Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

7.3.5 Controllable Capsule Endoscopy

7.3.5.1 Overview

7.3.5.2 Controllable Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

7.3.6 Storable Capsule Endoscopy

7.3.6.1 Overview

7.3.6.2 Storable Capsule Endoscope: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

7.3.7 Other Capsule Endoscopy

7.3.7.1 Overview

7.3.7.2 Other Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Drug Delivery

7.4.1 Overview

7.4.2 Drug Delivery: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Patient Monitoring

7.5.1 Overview

7.5.2 Patient Monitoring: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

8. North America Smart Pills Market Revenue and Forecasts To 2028 – Disease Indication

8.1 Overview

8.2 North America Smart Pills Market Share by Disease Indication - 2021 & 2028 (%)

8.2.1 North America North America Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

8.3 Gastrointestinal Diseases

8.3.1 Overview

8.3.2 Gastrointestinal Diseases: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

8.4 Neurological Disorders

8.4.1 Overview

8.4.2 Neurological Disorders: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

8.5 Cancer

8.5.1 Overview

8.5.2 Cancer: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

8.6 Inherited Disorders

8.6.1 Overview

8.6.2 Inherited Disorders: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

8.7 Other Disease Indications

8.7.1 Overview

8.7.2 Other Disease Indications: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

9. North America Smart Pills Market Revenue and Forecasts To 2028 – End User

9.1 Overview

9.2 North America Smart Pills Market Share by End User - 2021 & 2028 (%)

9.2.1 North America North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

9.5 Home Healthcare

9.5.1 Overview

9.5.2 Home Healthcare: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

10. North America Smart Pills Market – Regional Analysis

10.1 North America: North America Smart Pills Market

10.1.1 Overview

10.1.2 North America: North America Smart Pills Market, by Country, 2021 & 2028 (%)

10.1.2.1 US: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Overview

10.1.2.1.2 US: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3 US North America Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.1 US North America Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 US North America Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.5 US North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2 Canada: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Overview

10.1.2.2.2 Canada: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3 Canada North America Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.1 Canada North America Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 Canada North America Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.5 Canada North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 Mexico: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Overview

10.1.2.3.2 Mexico: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3 Mexico North America Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.1 Mexico North America Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 Mexico North America Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.5 Mexico North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. North America Smart Pills Market–Industry Landscape

11.1 Overview

11.2 Growth Strategies in the North America Smart Pills Market, 2021-2028

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 CapsoVision, Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Medtronic

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Check-Cap

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 PENTAX Medical

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Olympus Corporation

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Otsuka Holdings Co., Ltd.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

Table 2. North America North America Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 3. North America North America Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)

Table 4. North America North America Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 5. North America North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6. US North America Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7. US North America Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)

Table 8. US North America Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 9. US North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10. Canada North America Smart Pills Market, by Application-Revenue and Forecast to 2028 (USD Million)

Table 11. Canada North America Smart Pills Market, by Capsule Endoscopy -Revenue and Forecast to 2028 (USD Million)

Table 12. Canada North America Smart Pills Market, by Disease Indication -Revenue and Forecast to 2028 (USD Million)

Table 13. Canada North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico North America Smart Pills Market, by Application -Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico North America Smart Pills Market, by Capsule Endoscopy -Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico North America Smart Pills Market, by Disease Indication -Revenue and Forecast to 2028 (USD Million)

Table 17. Mexico North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 18. Recent Inorganic Growth Strategies in the North America Smart Pills Market

Table 19. Recent Organic Growth Strategies in the North America Smart Pills Market

Table 20. Glossary of Terms, North America Smart Pills Market

LIST OF FIGURES.

Figure 1. North America Smart Pills Market Segmentation

Figure 2. North America Smart Pills Market Overview

Figure 3. Capsule Endoscopy Segment Held Largest Share by Application in North America Smart Pills Market

Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. North America: PEST Analysis

Figure 6. North America Smart Pill Market Impact Analysis of Drivers and Restraints

Figure 7. North America Smart Pills Market – Revenue Forecast and Analysis – 2021- 2028

Figure 8. North America Smart Pills Market, by Application, 2021 & 2028 (%)

Figure 9. Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

Figure 10. Small Bowel Video Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11. Colon Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Controllable Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Storable Capsule Endoscope: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Other Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Drug Delivery: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Patient Monitoring: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. North America Smart Pills Market Share by Disease Indication - 2021 & 2028 (%)

Figure 18. Gastrointestinal Diseases: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19. Neurological Disorders: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20. Cancer: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21. Inherited Disorders: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22. Other Disease Indications: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23. North America Smart Pills Market Share by End User - 2021 & 2028 (%)

Figure 24. Hospitals and Clinics: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Research Institutes: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Home Healthcare: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27. North America: North America Smart Pills Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. North America: North America Smart Pills Market, by Country, 2021 & 2028 (%)

Figure 29. US: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Canada: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Mexico: North America Smart Pills Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Growth Strategies in the North America Smart Pills Market, 2021-2028

The List of Companies - North America Smart Pills Market

● Capso Vision, Inc.

● Medtronic

● Check-Cap

● PENTAX Medical

● Olympus Corporation

● Otsuka Holdings Co., Ltd.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Cam Locks Market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Cam Locks Market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TOP